Serum Autotaxin/ENPP2 Correlates with Insulin Resistance in Older Humans with Obesity

Reeves, Valerie L., Trybula, Joy S., Wills, Rachel C., Goodpaster, Bret H., Dube, John J., Kienesberger, Petra C., Kershaw, Erin E.

This work was supported by the following: NIH R01 DK090166 and Howard Hughes Medical Institute Physician-Scientist Early Career Award (EEK); NIH T32 DK007052 (VLR); NIH T35 DK065521 (JST); ADA Clinical Research Award, NIH R01 AG20128, NIH P30 DK46204, and NIH M01 RR00056 (BHG); NIH UL1-TR-000005 (CTSI).

Objective: Autotaxin (ATX) is an adipocyte-derived lysophospholipase D that generates the lipid signaling molecule lysophosphatidic acid (LPA). The ATX/LPA pathway in adipose tissue has recently been implicated in obesity and insulin resistance in animal models, but the role of circulating ATX in humans remains unclear. The aim of the present study was to determine the relationship between serum ATX and insulin resistance. Methods: Older (60-75 years), nondiabetic human participants with overweight or obesity (BMI 25-37 kg m(-2)) were characterized for metabolic phenotype including measures of energy, glucose, and lipid homeostasis. The relationship between serum ATX and metabolic parameters was then determined using correlative and predictive statistics. Results: Serum ATX was higher in females than in males. After controlling for sex, serum ATX correlated with multiple measures of adiposity and glucose homeostasis/insulin action. Serum ATX and BMI also independently predicted glucose infusion rate during a hyperinsulinemic euglycemic clamp and homeostatic model assessment of insulin resistance after controlling for sex and medication use. Conclusions: Serum ATX correlates with and predicts measures of glucose homeostasis and insulin sensitivity in older humans, suggesting that it may be a potential pathogenic factor and/or diagnostic/ therapeutic target for insulin resistance in this population.

Serum Autotaxin/ENPP2 Correlates with Insulin Resistance in Older Humans with Obesity Article